The downregulation of CCL13 protein expression in the plasma of MS patients in the third trimester of pregnancy and its increase after delivery may be related to the immune tolerance established during pregnancy, this expression pattern of CCL13 may reflect the disease activity of MS during pregnancy (14). The gene discussed is CCL13; the disease is myeloid sarcoma.